Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IVB Colon Cancer AJCC v7”

78 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 78 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04294264
What this trial is testing

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal Carcinoma+3 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT02873195
What this trial is testing

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colorectal CarcinomaRefractory Colorectal Carcinoma+3 more
Academic and Community Cancer Research United 133
Not applicableStudy completedNCT02148406
What this trial is testing

Programs to Support You During Chemotherapy (Pro-You)

Who this might be right for
Depressive SymptomsFatiguePsychosocial Effects of Cancer and Its Treatment+16 more
Vanderbilt-Ingram Cancer Center 3
Not applicableStudy completedNCT02728804
What this trial is testing

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

Who this might be right for
Stage IVA Colon CancerStage IVA Rectal CancerStage IVB Colon Cancer+1 more
SWOG Cancer Research Network 380
Testing effectiveness (Phase 2)Study completedNCT00077298
What this trial is testing

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 70
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Testing effectiveness (Phase 2)Study completedNCT01417494
What this trial is testing

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 102
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT04109924
What this trial is testing

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colon AdenocarcinomaMetastatic Rectal Adenocarcinoma+24 more
Roswell Park Cancer Institute 42
Testing effectiveness (Phase 2)WithdrawnNCT01270438
What this trial is testing

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Ended earlyNCT01729923
What this trial is testing

A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon Cancer+3 more
University of Washington 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Testing effectiveness (Phase 2)Study completedNCT03396926
What this trial is testing

Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer

Who this might be right for
Microsatellite StableMismatch Repair Protein ProficientStage III Colorectal Cancer AJCC v7+5 more
University of California, San Francisco 44
Not applicableStudy completedNCT01243372
What this trial is testing

Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,142
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Next Page